What We're Reading: Page 94
Industry reads hand-picked by our editors
Dec 09, 2022
-
The Wall Street Journal
Mark Cuban Has a New Job: Working at an Online Discount Pharmacy
-
Reuters
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say
-
The New York Times
The F.T.C.’s Bet on Rewriting Antitrust by Taking on Microsoft
-
MIT Technology Review
DNA that was frozen for 2 million years has been sequenced
Dec 08, 2022
-
NPR
Is lecanemab the Alzheimer’s drug that will finally make a difference?
-
The Wall Street Journal
How AI That Powers Chatbots and Search Queries Could Discover New Drugs
-
Boston Business Journal
Tech, biotech companies have laid off thousands in Mass. in 2022
-
Reuters
Takeda’s dengue vaccine wins EU approval
Dec 07, 2022
Dec 06, 2022
-
The Wall Street Journal
FDA Takes Tougher Line on Fast-Tracked Drugs
-
The New York Times
A Promising Trial Targets a Genetic Risk for Alzheimer’s
-
Reuters
Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
-
Science
Uganda’s disappearing Ebola outbreak challenges vaccine testing
Dec 05, 2022
-
The Wall Street Journal
Why You Can’t Find Wegovy, the Weight-Loss Drug
-
STAT
AAM’s Dan Leonard, president of generic drug lobby, ousted
-
Reuters
Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5
-
Financial Times
DeepMind spin-off steps up effort to use AI to create new drugs
Dec 02, 2022
Dec 01, 2022
-
Reuters
J&J sues Amgen over plan to sell drug similar to blockbuster Stelara
-
Boston Business Journal
What’s at stake in the battle over rights to Covid-19 vaccines
-
The Wall Street Journal
Biotech Company Says Citadel, Other Big Traders Manipulated Its Stock Price
Previous
